SHANGHAI, Oct. 14, 2021 /PRNewswire/ — GV20 Oncotherapy, a biotechnology company with unique expertise in novel target identification and antibody drug discovery in immuno-oncology, today announced the completion of i…
SHANGHAI, Oct. 14, 2021 /PRNewswire/ — GV20 Oncotherapy, a biotechnology company with unique expertise in novel target identification and antibody drug discovery in immuno-oncology, today announced the completion of i…